We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Aon
AON
$76B
| $40.3M | 0.09% |
151,743
-3,267
| -2% | -$939K |
|
277
XPO
XPO
$23.7B
| $40.3M | 0.09% |
1,462,268
+1,093,301
| +296% | +$34.8M |
|
|
EA
278
DELISTED
Electronic Arts
EA
| $40.2M | 0.09% |
331,119
-207,712
| -39% | -$26.5M |
|
279
Chemours
CC
$2.37B
| $40.1M | 0.09% |
1,300,670
+167,555
| +15% | +$6.16M |
|
280
CACI
CACI
$14.2B
| $39.9M | 0.09% |
144,731
+8,106
| +6% | +$2.25M |
|
281
Vail Resorts
MTN
$5.3B
| $39.7M | 0.09% |
183,632
+63,324
| +53% | +$15.5M |
|
282
Avnet
AVT
$7.92B
| $39.7M | 0.09% |
953,558
+130,466
| +16% | +$5.69M |
|
283
GE Aerospace
GE
$384B
| $39.5M | 0.09% |
1,021,122
+570,937
| +127% | +$27.7M |
|
284
Gen Digital
GEN
$17.5B
| $39.5M | 0.09% |
1,798,165
+939,064
| +109% | +$23.1M |
|
285
Estee Lauder
EL
$32B
| $39.3M | 0.09% |
157,264
-205,978
| -57% | -$52.3M |
|
286
Honeywell
HON
$78B
| $39.3M | 0.09% |
243,542
-88,991
| -27% | -$16M |
|
287
LKQ Corp
LKQ
$6.29B
| $38.9M | 0.09% |
804,250
-67,173
| -8% | -$3.31M |
|
288
Copa Holdings
CPA
$5.8B
| $38.9M | 0.09% |
642,803
+280,078
| +77% | +$19.7M |
|
289
Pinnacle West Capital
PNW
$12.2B
| $38.7M | 0.09% |
534,778
+168,255
| +46% | +$12.6M |
|
290
Charles River Laboratories
CRL
$12.8B
| $38.6M | 0.09% |
180,397
+59,131
| +49% | +$14.4M |
|
291
Oshkosh
OSK
$9.59B
| $38.6M | 0.09% |
479,496
+135,172
| +39% | +$12.4M |
|
292
Intercontinental Exchange
ICE
$84.4B
| $38.5M | 0.09% |
409,321
-62,461
| -13% | -$6.68M |
|
293
Rollins
ROL
$18.2B
| $38.3M | 0.09% |
1,100,204
-92,040
| -8% | -$3.16M |
|
294
Caterpillar
CAT
$387B
| $38.2M | 0.09% |
215,352
-68,078
| -24% | -$14.3M |
|
295
Advanced Micro Devices
AMD
$789B
| $37.8M | 0.09% |
494,541
-212,949
| -30% | -$19.9M |
|
296
Ecolab
ECL
$79.9B
| $37.4M | 0.08% |
248,160
-109,929
| -31% | -$18.2M |
|
297
Flowers Foods
FLO
$1.57B
| $37.3M | 0.08% |
1,417,813
+66,832
| +5% | +$1.76M |
|
298
Werner Enterprises
WERN
$2.25B
| $37.3M | 0.08% |
986,021
+130,728
| +15% | +$5.15M |
|
299
Assurant
AIZ
$14.3B
| $37.3M | 0.08% |
220,860
-152,984
| -41% | -$27.7M |
|
300
Mattel
MAT
$4.23B
| $37.2M | 0.08% |
1,671,770
-52,420
| -3% | -$1.24M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.